Patent directory · USPTO A61K / A61P
Patents matching “The Regents of the University of California”
3,494 pharma patents match "The Regents of the University of California" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 3,494 pharmaceutical patents matching "The Regents of the University of California" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11999693
Synthetic sphingolipid-like molecules, drugs, methods of their synthesis and methods of treatment
granted -
US 11992532
Hydrogels and methods of using the same
granted -
US 11992495
Enhancing GABA's ability to modulate immune responses
granted -
US 11987600
Contraceptive use of triterpenoids
granted -
US 11986442
Inhibition of respiratory complex III by ligands that interact with a regulatory switch
granted -
US 11980645
Bile acids and use in disease treatment
granted -
US 11981571
Identification and optimization of carbon radicals on hydrated graphene oxide for ubiquitous antibacterial coatings
granted -
US 11976309
Fusion proteins and methods for site-directed genome editing
granted -
US 11974988
Neuroprotective compositions and methods of using the same
granted -
US 11975035
Methods for treating microbial infections using caudovirales bacteriophages
granted -
US 11976293
Optimized lentiviral vector for stem cell gene therapy of hemoglobinopathies
granted -
US 11974992
Use of serotonin 5-HT1A receptor agonists to treat diseases associated with sudden unexpected death in epilepsy
granted -
US 11969501
Auris formulations for treating otic diseases and conditions
granted -
US 11970711
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
granted -
US 11965159
Compositions and methods for regulating proteins and nucleic acids activities
granted -
US 11963533
Compositions and methods for treating Liberibacter diseases and other bacterial diseases
granted -
US 11957655
Methods of treating hearing loss
granted -
US 11958901
Anti-CXCR5 antibodies and compositions and uses thereof
granted -
US 11951176
Stabilization of glucagon by trehalose glycopolymer nanogels
granted -
US 11952362
Compositions and methods for treating epigenetic disease
granted -
US 11952366
Substituted 1,3,5-triazines as inhibitors for a rho family of GTP-ases
granted -
US 11946049
tRNA/pre-miRNA compositions and use in treating cancer
granted -
US 11944679
Genome-wide identification of immune evasion functions in a virus
granted -
US 11938149
Treatment of neurodegenerative disease with sodium chlorite
granted